FocusCORONAVIRUS

HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19

See allHide authors and affiliations

Science Immunology  29 May 2020:
Vol. 5, Issue 47, eabc5367
DOI: 10.1126/sciimmunol.abc5367

Abstract

JAK kinase inhibitors are being investigated as a way of managing cytokine storm in patients with severe COVID-19.

This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

View Full Text

Stay Connected to Science Immunology